<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01831882</url>
  </required_header>
  <id_info>
    <org_study_id>26529</org_study_id>
    <nct_id>NCT01831882</nct_id>
  </id_info>
  <brief_title>Identifying Biological Markers for Severe Depression</brief_title>
  <official_title>Identifying Biological Markers for Severe Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pritzker Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to investigate the biological components of major
      depression. The investigators are particularity interested in genetic variation and how it
      contributes to cortisol (because cortisol is higher in severe depression than mild depression
      or healthy controls) and how it contributes to clinical symptoms, especially suicidal
      ideation/behavior and psychosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetics</measure>
    <time_frame>1 year</time_frame>
    <description>Blood will be drawn for gene expression, which includes genetics and metallothionein assessments. Blood will also be drawn for later assay of immune function/measures and neurotophins, and for future studies.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Physiologic</measure>
    <time_frame>1 year</time_frame>
    <description>Cortisol hormone levels will be measured in blood (suppression test), hair and saliva samples.</description>
  </other_outcome>
  <other_outcome>
    <measure>Neurocognition</measure>
    <time_frame>1 year</time_frame>
    <description>Standardized neuropsychological measures will be used to assess neurocognition including, tests involving verbal learning, visual reproduction, attentional flexibility, and memory.</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical psychiatric measures will be used to assess depression (HAM-D), psychotic features, suicidality, childhood trauma, and anhedonia.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Major Depressive Disorder</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      We will be retaining biospecimens including, whole blood, serum, hair and saliva tissues
      samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Inpatient hospitals, outpatient clinics, community.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for depressed patients:

          1. Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) diagnosis
             of Unipolar Major Depressive Disorder with or without psychotic features.

          2. 21-item Hamilton Depression Rating Scale (HDRS) score greater than or equal to 21.

          3. Thase Core Endogenomorphic Scale score greater than or equal to 8 on the items
             included in the 21-item HDRS.

          4. Between 18 - 70 years of age.

          5. If currently taking antipsychotic, antidepressant, anticonvulsant, and/or
             mood-stabilizing medications, must be stable on the medication for at least one-week
             prior to entering the study.

          6. Pre-existing (current) primary treating psychiatrist for subjects with psychotic
             features.

          7. Any secondary diagnoses from the anxiety disorder spectrum is acceptable. Primary
             pre-existing chronic Obsessive-Compulsive Disorder (OCD) will be an exclusion
             criteria.

        Inclusion criteria for healthy controls:

          1. Between 18 - 70 years of age.

          2. Have a HAM-D score of less than or equal to 5.

        Exclusion Criteria for depressed patients:

          1. Electroconvulsive Therapy (ECT) in the 6 months prior to the study.

          2. Abuse of drugs or alcohol in the 6 months prior to study.

          3. Unstable or untreated hypertension or cardiovascular disease.

          4. Use of additional prescription medications, street drugs, or alcohol during the week
             before the study.

          5. Any Axis II diagnosis or traits which would make participation in the study difficult.

          6. Current pregnancy or lactation.

          7. Post-partum depression

          8. Diagnosis of obsessive-compulsive disorder

          9. History of significant cognitive decline

        Exclusion criteria for healthy controls:

          1. Personal history of Axis I or Axis II disorders.

          2. Active unstable medical problems.

          3. Abuse of drugs or alcohol in the 6 months prior to study.

          4. Use of additional prescription medications, street drugs, or alcohol during the week
             before the study.

          5. Currently pregnant or lactating.

          6. History of significant cognitive decline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Schatzberg, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maureen H Chang, B.S.</last_name>
    <phone>650-725-4620</phone>
    <email>mhchang@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica A Hawkins, B.A.</last_name>
    <phone>650-723-8323</phone>
    <email>jhawk@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, Irvine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Patterson, Ph.D.</last_name>
      <phone>714-456-1663</phone>
      <email>jvpatter@uci.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tia E Martin</last_name>
      <phone>714-456-1663</phone>
      <email>temartin@uci.edu</email>
    </contact_backup>
    <investigator>
      <last_name>William E. Bunney, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Patterson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Stein, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Vawter, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Preston Cartagena, PsyD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Blynn Bunney, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven G. Potkin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>P. Adolfo Sequeira Medieta, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University, Department of Psychiatry and Behavioral Sciences</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maureen H Chang, B.S.</last_name>
      <phone>650-725-4620</phone>
      <email>mhchang@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica A Hawkins, B.A.</last_name>
      <phone>650-723-8323</phone>
      <email>jhawk@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alan Schatzberg, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Keller, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rowena Gomez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Justin A. Birnbaum, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rona Hu, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Marino, PhD</last_name>
      <phone>914-997-8691</phone>
      <email>pam2029@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Benjamin Brody, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Kocsis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jack Barchas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barnett Meyers, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricia Marino, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meredith Grossman, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2013</study_first_submitted>
  <study_first_submitted_qc>April 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2013</study_first_posted>
  <last_update_submitted>October 18, 2016</last_update_submitted>
  <last_update_submitted_qc>October 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Alan Schatzberg</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

